/assets/images/provider/photos/2568308.png)
Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Cancer proteogenomics: current impact and future prospects
Phenanthridine sulfonamide derivatives as potential DPP-IV inhibitors: design, synthesis and biological evaluation
MDPI Pharmaceuticals (2025)
sales decline was driven by lower realized prices due to an unfavorable channel mix, rebate enhancements, the launch of additional affordability programs and changes in coverage gap legislation." Sales of Ozempic increased in the US and EMEA, whereas sales of Levemir and Victoza decreased in the US
Pricing Breakdown Lab work is recommended but not required and is not included in your plan
Values are expressed as mean standard deviation (SD) for parametric data and median (25th, 75th percentiles) for nonparametric data
US$ 27.07
US$ 25.65
US$ 22.38
US$ 20.52
US$ 24.72
US$ 22.14
